• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles Benzimidazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles

Comprehensive Overview of 3-(5-Methyl-1H-benzimidazol-2-yl)propan-1-amine Dihydrochloride (CAS No. 1169950-70-2)

3-(5-Methyl-1H-benzimidazol-2-yl)propan-1-amine Dihydrochloride (CAS No. 1169950-70-2) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its benzimidazole core structure, is widely studied for its potential applications in drug development and molecular biology. The dihydrochloride salt form enhances its solubility, making it a preferred choice for various experimental protocols. Researchers are particularly interested in its role as a building block for synthesizing more complex molecules, especially those targeting enzyme inhibition and receptor modulation.

The benzimidazole moiety in 3-(5-Methyl-1H-benzimidazol-2-yl)propan-1-amine Dihydrochloride is a key feature that contributes to its biological activity. This structural motif is commonly found in compounds with antimicrobial, antiviral, and anticancer properties. Recent studies have explored its potential in targeted therapy, particularly in the context of personalized medicine. The compound's ability to interact with specific biological targets makes it a valuable tool for investigating signal transduction pathways and cellular responses.

In the realm of drug discovery, 3-(5-Methyl-1H-benzimidazol-2-yl)propan-1-amine Dihydrochloride is often utilized as a scaffold for designing novel therapeutic agents. Its amine functionality allows for further chemical modifications, enabling researchers to tailor its properties for specific applications. For instance, it has been investigated in the development of small-molecule inhibitors for kinases and other enzymes involved in disease progression. The compound's versatility underscores its importance in modern medicinal chemistry.

Another area of interest is the compound's potential role in neuropharmacology. Preliminary studies suggest that derivatives of 3-(5-Methyl-1H-benzimidazol-2-yl)propan-1-amine Dihydrochloride may interact with neurotransmitter receptors, offering insights into the treatment of neurological disorders. This aligns with the growing demand for neuroprotective agents and cognitive enhancers, topics frequently searched by both professionals and the general public. The compound's unique structure provides a foundation for exploring these avenues further.

From a synthetic perspective, the preparation of 3-(5-Methyl-1H-benzimidazol-2-yl)propan-1-amine Dihydrochloride involves multi-step organic reactions, often requiring high-purity starting materials and controlled conditions. The dihydrochloride salt is typically obtained through acidification of the free base, ensuring stability and ease of handling. Researchers emphasize the importance of quality control in its synthesis, as impurities can significantly affect experimental outcomes. This aspect is particularly relevant in preclinical studies, where reproducibility is critical.

The compound's physicochemical properties, such as its melting point, solubility, and stability, are well-documented in the literature. These parameters are essential for formulating drug candidates and optimizing their delivery systems. For example, its solubility in aqueous solutions makes it suitable for in vitro assays, while its stability under various pH conditions ensures reliable performance in biological matrices. Such characteristics are frequently queried by scientists seeking to incorporate the compound into their research protocols.

In addition to its pharmaceutical applications, 3-(5-Methyl-1H-benzimidazol-2-yl)propan-1-amine Dihydrochloride has been explored in material science. Its aromatic system and functional groups allow it to participate in supramolecular interactions, making it a candidate for designing advanced materials with tailored properties. This interdisciplinary potential highlights the compound's relevance beyond traditional drug development, appealing to a broader audience of researchers and innovators.

As the scientific community continues to uncover new applications for 3-(5-Methyl-1H-benzimidazol-2-yl)propan-1-amine Dihydrochloride, its demand in research laboratories and industrial settings is expected to rise. The compound's versatility, coupled with its well-characterized properties, positions it as a valuable asset in the pursuit of scientific breakthroughs. Whether in drug design, neuropharmacology, or material science, this molecule offers endless possibilities for innovation and discovery.

• 98072-00-5(1H-Benzimidazole-1-pentanamine,hydrochloride (1:1))
• 24625-24-9(1H-Benzimidazole-2-ethanamine,6-methyl-, hydrochloride (1:2))
• 630091-56-4(2-Isobutyl-5-methyl-1H-benzoimidazole)
• 7479-04-1(1H-Benzimidazole,2-butyl-6-methyl-)
• 5473-06-3(1H-Benzimidazole,6-methyl-2-propyl-)
• 5059-50-7(1H-Benzimidazole,2-heptyl-6-methyl-)
• 88704-76-1(1H-Benzimidazole-2-decanamine, hydrochloride (1:1))
• 1185294-80-7(2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-ethylamine hydrochloride)
• 630091-54-2(2-(5-Methyl-1H-benzimidazol-2-yl)ethylamine Dihydrochloride)
• 630091-53-1(1H-Benzimidazole-2-propanamine,5-methyl-(9CI))